UBS’s VeriSign VRSN Stock Holding History

UBS’s Portfolio VRSN Stock Details VRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-10,300	Closed	-$503K	–	10800
2014 Q2	$503K	Buy	10,300 +10,000	+3,333%	+$498K	﹤0.01%	4214
2014 Q1	$16K	Buy	+300	New	+$17K	﹤0.01%	8392
2013 Q4	–	Sell	-300	Closed	-$15K	–	10801
2013 Q3	$15K	Sell	300 -1,400	-82%	-$67.6K	﹤0.01%	8398
2013 Q2	$76K	Buy	+1,700	New	+$78.8K	﹤0.01%	6231

Other funds holding VRSN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CGT

Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

UBS's VRSN Position: Q3 2014 in Review

UBS reduced its VeriSign (VRSN) stake by 4.5% in Q3 2014, selling an estimated $131K and leaving 51,704 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2578.

UBS first reported a position in VRSN in Q2 2013 and has held it in 6 quarters since. 359 funds tracked by Wall St. Rank hold VRSN as of Q3 2014.

UBS held 51,704 shares of VeriSign worth $2.85M as of Q3 2014.
UBS sold 2,421 VeriSign shares in Q3 2014, an estimated $131K.
VeriSign made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2578 holding.
UBS first reported a position in VeriSign in Q2 2013 and has held it in 6 quarters since.
359 funds tracked by Wall St. Rank held VeriSign as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.